Medical News

RSS

NIH renews second year of a 5-year licensing agreement with BIOBASE

BIOBASE, a leading provider of biological databases and software for the life sciences industry, announced today the renewal of the second year of a 5-year licensing agreement with the National Institutes of Health (NIH). This 5-year contract provides all 27 NIH institutions with locally installed access to the BIOBASE Knowledge Library™ which includes the premier TRANSFAC® and PROTEOME® databases.

10 Sep 2009

Research on the role of microRNAs in cellular processes

RNAs, serving as a mere intermediary between DNA and proteins, were long regarded as a poor relation by researchers, attracting little interest. However, following the discovery of small RNAs known as microRNAs, they have increasingly been moving into the limelight. MicroRNAs bind to messenger RNA (mRNA), thereby regulating the translation of genes into proteins.

10 Sep 2009

Luna Innovations posts year-on-year decline in second-quarter 2009 revenues

Luna Innovations Incorporated (NASDAQ:LUNA), a company focusing on sensing & instrumentation and pharmaceutical nanomedicines, today announced its financial results for the quarter ended June 30, 2009.

10 Sep 2009

Symposium on innovations in health care experience to be hosted

The Mayo Clinic Center for Innovation will host Transform, a collaborative symposium on innovations in health care experience and delivery, Sept. 13-15, http://centerforinnovation.mayo.edu/transform. Transform will feature nationally recognized speakers discussing topics focused on innovation methodology and innovations in health care delivery models, including Web-based tools.

10 Sep 2009

SRA to provide scientific peer review services to Cancer Prevention and Research Institute of Texas

SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.

10 Sep 2009

Ketamine shows rapid antidepressant effects

Researchers have now explored ketamine's effects on suicidality in patients with treatment-resistant depression, and are publishing their results in the September 1st issue of Biological Psychiatry. Ketamine acutely reduced suicidal thoughts when patients were assessed 24 hours after a single infusion. This reduction in suicidality was maintained when patients received repeated doses over the next two weeks.

10 Sep 2009

TI Pharma: A role model of public-private cooperation and partnership

The Danish Council for Strategic Research is visiting the Dutch Top Institute Pharma (TI Pharma) on Thursday, September 10. The purpose of their visit is to learn about the unique Dutch approach on public-private cooperation and the concrete results that are being booked by this institute.

10 Sep 2009

Efficacy of Ore Pharmaceuticals' lead drug candidate discussed

Ore Pharmaceuticals Inc., announced today the publication of an article in the online version of the journal Inflammation Research titled, “Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice.”

10 Sep 2009

Vita-Tech donates vitamins to support nutritionally disadvantaged population in West Africa

Vita-Tech International, Inc. has donated one ton of vitamins to Conakry, Guinea, West Africa, to support nutritionally disadvantaged populations in polio treatment centers throughout the country, as well as rural villages in the area surrounding Conakry. "This donation will provide nutritional support for hundreds of people for a long period, with follow-up shipments planned to insure continuity of care," according to Tom Tierney, President of Vita-Tech.

10 Sep 2009

Healthcare reform explained

A bevy of legislation is flooding Capitol Hill on healthcare reform. With President Obama’s speech kicking debate on these initiatives into high gear, Eric Zimmerman, a partner in the Health Law Department of leading law firm McDermott Will & Emery, weighs in on the issues:

10 Sep 2009

Physicians and patients underestimate promotional volume of Actonel

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that patients and physicians most frequently recall Roche's Boniva messages among the ten surveyed osteoporosis brands likely as a result of the Sally Field marketing campaign.

10 Sep 2009

TPC seeks President Obama's support for private and community foundations in the field of health

As the nation awaits President Obama's address on health care reform to a joint session of Congress, The Philanthropic Collaborative (TPC) sent today a letter to the President seeking his support for the efforts of private and community foundations in the field of health.

10 Sep 2009

Family mealtimes promote healthy eating habits

In a new report, University of Illinois professor Barbara H. Fiese urges local, state, and federal governments, businesses, and community leaders to promote family mealtimes as a matter of public policy.

10 Sep 2009

Obama's big speech: Advice and history

As President Obama prepares for his big health care speech tonight, major players from the last health care debate offer him advice. Obama also has earlier health care experiences of his own to draw from.

10 Sep 2009

Huron Consulting Group finds place in Modern Healthcare’s 2009 list

Huron Consulting Group (NASDAQ: HURN), a leading provider of business consulting services, today announced its ranking in Modern Healthcare’s 2009 list of the largest healthcare management consulting firms. Huron was listed second out of 15 healthcare consulting firms, ranked according to total 2008 provider revenue.

10 Sep 2009

ThermoGenesis releases results for fourth quarter and fiscal year 2009

ThermoGenesis Corp. , a leading supplier of innovative products for processing and storing adult stem cells, today reported results for the fourth quarter and all of fiscal 2009.

10 Sep 2009

Cempra commences Phase 2/3 clinical study of CEM-102 for treating acute bacterial skin structure infections

Cempra Pharmaceuticals today announced that enrollment is underway in an adaptive design Phase 2/3 clinical study with CEM-102 for patients suffering from acute bacterial skin structure infections (ABSSI). CEM-102 is an oral antibiotic with an established record of treating staphylococcal infections outside the United States, including those due to methicillin-resistant Staphylococcus aureus (MRSA).

10 Sep 2009

Everyone must have access to affordable and quality health care: Regence BlueCross BlueShield

"These are extraordinary times. Our nation is in the midst of a pivotal conversation about health care reform. I applaud our nation's leaders for making this difficult issue a priority.

10 Sep 2009

President Obama’s health care address to Congress broadcasted

Today, Health and Human Services Secretary Kathleen Sebelius released a radio actuality previewing President Obama’s health care address to Congress on Wednesday evening. Radio stations and Web sites wishing to download the audio for broadcast can find it on the www.healthreform.gov Web site.

10 Sep 2009

Special issue of Optometry & Vision Development explores autism

Autism. What is its cause? How does it affect brain anatomy, electrophysiology, visual function and perception? What must we do to meet the needs of these patients? How can optometrists as health care providers be in the vanguard for screening for this spectrum of disorders?

10 Sep 2009